Private equity investment committee proposal - medpace lbo returns

Detalhes bibliográficos
Autor(a) principal: Pérez, Mafalda Pinto De Sousa Von Hafe
Data de Publicação: 2022
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/163018
Resumo: Medpace is a CRO company focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharma and medical-device industries. Its strong positioning in a niche market, the high projected industry growth, its strong and stable FCFs, and experienced management team make it an ideal target, which would be further improved by our developed business plan that will enhance its operations, expand internationally, and capitalize on M&A trends. The business plan is expected to deliver high returns, translating into a money multiple of 3.28x and an IRR of 26.84%, which are further analysed in the individual part of this paper.
id RCAP_4ad5d27ecbd2625ce31a89bc01228d8a
oai_identifier_str oai:run.unl.pt:10362/163018
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Private equity investment committee proposal - medpace lbo returnsContract research organization (Cro)Research & development (R&D)Mergers & acquisitions (M&A)BiopharmaLeverage buyout (Lbo)Money multiple (Mm)Internal rate of return (Irr)Private equity (Pe)Domínio/Área Científica::Ciências Sociais::Economia e GestãoMedpace is a CRO company focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharma and medical-device industries. Its strong positioning in a niche market, the high projected industry growth, its strong and stable FCFs, and experienced management team make it an ideal target, which would be further improved by our developed business plan that will enhance its operations, expand internationally, and capitalize on M&A trends. The business plan is expected to deliver high returns, translating into a money multiple of 3.28x and an IRR of 26.84%, which are further analysed in the individual part of this paper.Santos, FábioRUNPérez, Mafalda Pinto De Sousa Von Hafe2024-02-02T12:26:16Z2023-01-192022-12-162023-01-19T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/163018TID:203311914enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:46:04Zoai:run.unl.pt:10362/163018Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:59:13.722936Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Private equity investment committee proposal - medpace lbo returns
title Private equity investment committee proposal - medpace lbo returns
spellingShingle Private equity investment committee proposal - medpace lbo returns
Pérez, Mafalda Pinto De Sousa Von Hafe
Contract research organization (Cro)
Research & development (R&D)
Mergers & acquisitions (M&A)
Biopharma
Leverage buyout (Lbo)
Money multiple (Mm)
Internal rate of return (Irr)
Private equity (Pe)
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
title_short Private equity investment committee proposal - medpace lbo returns
title_full Private equity investment committee proposal - medpace lbo returns
title_fullStr Private equity investment committee proposal - medpace lbo returns
title_full_unstemmed Private equity investment committee proposal - medpace lbo returns
title_sort Private equity investment committee proposal - medpace lbo returns
author Pérez, Mafalda Pinto De Sousa Von Hafe
author_facet Pérez, Mafalda Pinto De Sousa Von Hafe
author_role author
dc.contributor.none.fl_str_mv Santos, Fábio
RUN
dc.contributor.author.fl_str_mv Pérez, Mafalda Pinto De Sousa Von Hafe
dc.subject.por.fl_str_mv Contract research organization (Cro)
Research & development (R&D)
Mergers & acquisitions (M&A)
Biopharma
Leverage buyout (Lbo)
Money multiple (Mm)
Internal rate of return (Irr)
Private equity (Pe)
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
topic Contract research organization (Cro)
Research & development (R&D)
Mergers & acquisitions (M&A)
Biopharma
Leverage buyout (Lbo)
Money multiple (Mm)
Internal rate of return (Irr)
Private equity (Pe)
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
description Medpace is a CRO company focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharma and medical-device industries. Its strong positioning in a niche market, the high projected industry growth, its strong and stable FCFs, and experienced management team make it an ideal target, which would be further improved by our developed business plan that will enhance its operations, expand internationally, and capitalize on M&A trends. The business plan is expected to deliver high returns, translating into a money multiple of 3.28x and an IRR of 26.84%, which are further analysed in the individual part of this paper.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-16
2023-01-19
2023-01-19T00:00:00Z
2024-02-02T12:26:16Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/163018
TID:203311914
url http://hdl.handle.net/10362/163018
identifier_str_mv TID:203311914
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138172234366976

Registros relacionados